{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "9300258",
  "DateCompleted": {
    "Year": "1997",
    "Month": "11",
    "Day": "24"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "06",
    "Day": "24"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0014-2999",
      "JournalIssue": {
        "Volume": "332",
        "Issue": "3",
        "PubDate": {
          "Year": "1997",
          "Month": "Aug",
          "Day": "13"
        }
      },
      "Title": "European journal of pharmacology",
      "ISOAbbreviation": "Eur J Pharmacol"
    },
    "ArticleTitle": "Effect of methamphetamine on tryptophan hydroxylase activity: role of hyperthermia.",
    "Pagination": {
      "StartPage": "263",
      "EndPage": "265",
      "MedlinePgn": "263-5"
    },
    "Abstract": {
      "AbstractText": [
        "A single administration of methamphetamine (15 mg/kg, s.c.) decreased activity of the 5-hydroxytryptamine (5-HT)-synthesizing enzyme, tryptophan hydroxylase, in rat striatum 1 h after administration. Methamphetamine also increased core body temperatures by greater than 3 degrees C in these rats. Prevention of hyperthermia attenuated the methamphetamine-induced decrease in tryptophan hydroxylase activity. Core temperature at the time of injection (from 37.7 degrees C to 40 degrees C) did not influence the magnitude of this decrease. Moreover, augmenting, methamphetamine-induced hyperthermia (from approximately 41 to 42 degrees C) did not cause a further decrease in tryptophan hydroxylase activity. These data indicate that temperature contributes to, but is not solely responsible for, methamphetamine-induced 5-HT neuronal impairment."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacology and Toxicology, University of Utah, Salt Lake City 84112, USA."
          }
        ],
        "LastName": "Fleckenstein",
        "ForeName": "A E",
        "Initials": "AE"
      }
    ],
    "GrantList": [
      {
        "GrantID": "DA 00869",
        "Acronym": "DA",
        "Agency": "NIDA NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "DA 04221",
        "Acronym": "DA",
        "Agency": "NIDA NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, U.S. Gov't, P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Eur J Pharmacol",
    "NlmUniqueID": "1254354",
    "ISSNLinking": "0014-2999"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "44RAL3456C",
      "NameOfSubstance": "Methamphetamine"
    },
    {
      "RegistryNumber": "EC 1.14.16.4",
      "NameOfSubstance": "Tryptophan Hydroxylase"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Body Temperature"
    },
    {
      "QualifierName": [
        "drug effects",
        "enzymology"
      ],
      "DescriptorName": "Corpus Striatum"
    },
    {
      "QualifierName": [
        "metabolism",
        "physiopathology",
        "prevention & control"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Methamphetamine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats, Sprague-Dawley"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Tryptophan Hydroxylase"
    }
  ]
}